Abstract
HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Current HIV Research
Title: Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Volume: 7 Issue: 5
Author(s): Eoin J. Cotter, Peter P. Doran and William G. Powderly
Affiliation:
Abstract: HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Export Options
About this article
Cite this article as:
Cotter J. Eoin, Doran P. Peter and Powderly G. William, Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment, Current HIV Research 2009; 7 (5) . https://dx.doi.org/10.2174/157016209789346282
DOI https://dx.doi.org/10.2174/157016209789346282 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanomaterials-based Polymerase Chain Reactions for DNA Detection
Current Organic Chemistry The Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Infectious Disorders - Drug Targets Conformational Hotspots of Dengue Virus NS5 RdRp
Current Bioinformatics Fibrinogen Signal Transduction as a Mediator and Therapeutic Target in Inflammation:Lessons from Multiple Sclerosis
Current Medicinal Chemistry Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases
Current Drug Targets Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Gibbs Sampling Shows Possibilities of B-Cell Epitope Signatures
Protein & Peptide Letters Novel Targets for the Development of Anti-Herpes Compounds
Infectious Disorders - Drug Targets Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Potential Factors Induced by Filoviruses that Lead to Immune Supression
Current Molecular Medicine Neurological Aspects of Medical Use of Cannabidiol
CNS & Neurological Disorders - Drug Targets Understanding Helicases as a Means of Virus Control
Current Pharmaceutical Design Under the Microscope: Focus on Chlamydia pneumoniae Infection and Multiple Sclerosis
Current Neurovascular Research Current Experimental Therapy for Alzheimers Disease
Current Neuropharmacology Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Proteases in Mosquito Borne Diseases: New Avenues in Drug Development
Current Topics in Medicinal Chemistry BACE1 Levels Correlate with Phospho-Tau Levels in Human Cerebrospinal Fluid
Current Alzheimer Research Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review
Current Molecular Pharmacology